CATO supplies 21P699C5FC
1312547-19-5
Samatasvir [USAN:INN]
Carbamic acid, N-((1R)-2-((2S)-2-(5-(4-(6-(2-((2S)-1-((2S)-2-((methoxycarbonyl)amino)-3-methyl-1-oxobutyl)-2-pyrrolidinyl)-1H-benzimidazol-6-yl)thieno(3,2-b)thien-3-yl)phenyl)-1H-imidazol-2-yl)-1-pyrrolidinyl)-2-oxo-1-phenylethyl)-, methyl ester
Methyl N-((1R)-2-((2S)-2-(5-(4-(6-(2-((2S)-1-((2S)-2-((methoxycarbonyl)amino)-3-methylbutanoyl)pyrrolidin-2-yl)-3H-benzimidazol-5-yl)thieno(3,2-b)thiophen-3-yl)phenyl)-1H-imidazol-2-yl)pyrrolidin-1-yl)-2-oxo-1-phenylethyl)carbamate
IDX18719
Samatasvir
UNII-21P699C5FC
IDX 18719
IDX 719
IDX719
IDX-719 (CAS 1312547-19-5), a pharmaceutical standards reference standard manufactured under ISO 17034 accreditation. Molecular formula: C47H48N8O6S2. Molecular weight: 885.06 g/mol. Batch-specific COA and technical support are available on request.
Physical & Chemical Properties
Molecular Formula
C47H48N8O6S2
Molecular Weight
885.06 g/mol
Purity
97%+
Storage
Store in a cool place (≤25°C), protect from light, keep sealed and dry
Solubility (reference)
Soluble in DMSO, DMF, methanol
Stability
May oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light; Hygroscopic; reseal immediately after opening